Fig. 2
From: Neurobehavioral outcomes of neonatal asymptomatic congenital cytomegalovirus infection at 12-months
Infants with asymptomatic cCMV performed equivalently to or better than healthy control infants on all of the neurobehavioral measures tested. Pictured here are the Mullen and RBS-EC Composite Scores and the four main ITSEA subscales. On the Mullen composite score, asymptomatic cCMV infants performed better than healthy control infants, F(2, 237) = 11.42, p = 0.03. On the RBS-EC Composite Endorsed, asymptomatic cCMV infants performed no different than healthy controls, F(2,145) = 0.4597, p = 0.64. On the ITSEA subscales, asymptomatic cCMV infants also performed no different than healthy controls, with all p > 0.4